Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.41 |
| ▸ | TOP1 | P11387 | 1/20 | 0.41 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13203116 | 0.84 | CYP19A1 (0.63) | CYP19A1KDM4EMAPTMEN1KMT2A | |
| SCHEMBL14425540 | 0.84 | CYP19A1 (0.63) | CYP19A1KDM4EMAPTMEN1KMT2A | |
| SCHEMBL411336 | 0.84 | ALDH1A1 (0.53) | ALDH1A1CTDSP1TDP1 | |
| Biphenyl SCHEMBL28360045 | 0.84 | ALDH1A1 (0.53) | ALDH1A1CTDSP1TDP1 | |
| SCHEMBL28316619 | 0.84 | KDM4E (0.43) | CYP19A1KDM4EMAPTMEN1KMT2A | |
| SCHEMBL28196237 | 0.83 | MAPT (0.65) | CYP19A1KDM4EMAPTMEN1KMT2A | |
| SCHEMBL4355827 | 0.83 | MAPT (0.65) | CYP19A1KDM4EMAPTMEN1KMT2A | |
| SCHEMBL31291015 | 0.83 | MAPT (0.65) | CYP19A1KDM4EMAPTMEN1KMT2A | |
| SCHEMBL13916912 | 0.82 | CYP19A1 (0.61) | CYP19A1KDM4EMAPTMEN1KMT2A | |
| SCHEMBL13203061 | 0.82 | CYP19A1 (0.61) | CYP19A1KDM4EMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8178215-B2 | Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound | PIONEER CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-8178215-B2 | Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound | PIONEER CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORPORATION (JO) | 2009-09-24 | — | — | US | disclosed |
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORPORATION (JO) | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | SLCO4C1, SLCO2A1, SLCO2B1 | CYP19A1 1485/4885KDM4E 2187/4885MAPT 2592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.